Strong Revenue Growth:
Independent market research estimates indicate annualized revenue roughly doubled in 2024, pointing to rapid topline expansion into 2025. This trajectory aligns with other scale markers like cumulative sessions growth.
Market Expansion:
Company materials describe nationwide therapy and psychiatry availability and 10M+ cumulative sessions by mid‑2026, indicating expanding reach and utilization. Press mentions of 21,000+ licensed providers with next‑day access further underscore capacity growth.
Strategic Partnerships:
Recent references to integrations with major insurers and health‑system/employer channels (e.g., Kaiser regions, Stanford Health Care Alliance, Amazon programs) suggest deepening distribution. Active hiring for partnership roles and multiple plan collaborations reinforce go‑to‑market scaling.
